Clinical Trials
Bodyflow® Therapy has been independently clinically trialled by some of the world’s leading researchers in the fields of:
Lymphoedema – Professor Neil Piller
Professor Neil Piller a Lymphologist from Flinders Medical Centre in Adelaide has been conducting trials of Bodyflow® Therapy on Lymphoedema patients. With over 300 works published and presented, Professor Piller is one of the world’s key researchers on the treatment, management and recognition of Lymphoedema.
In this trial, patients with longstanding Lymphoedema of the legs were selected and offered treatment three times per week for 4 weeks with each treatment being of 30 minutes duration. Over the weekends and at the end of the trial, patients were required to wear a compression garment.
The findings of this study were presented at:
- Australasian College of Phlebology Conference, 18-21st of September 2007, Double Bay Sydney. Download Abstract
- International Congress of Lymphology, 26th –29th September 2007, Shanghai, China.
- American College of Phlebology Conference, 8-11th November 2007, Arizona, United States.
- Australian Lymphology Association Conference, 27th-29th March 2008, Perth, Australia.
Future presentations of this study will take place at:
- 22nd International Congress of Lymphology, 21st-25th September 2009, Sydney, Australia.
Sports Recovery – Simon Sostaric
Simon Sostaric from Victoria University is an exercise physiologist and coach with extensive international experience in physical preparation and performance monitoring of world-class athletes. Much of Simon’s work during the past 12 years has been investigating and implementing a multitude of training and recovery methods.
Sostaric’s study investigated the effects of Bodyflow® treatment on exercise induced skeletal muscle damage and soreness (DOMS – Delayed Onset Muscle Soreness), and subsequent contractile function and performance in humans. Sostaric explored the biochemical markers, exercise performance, and subjective pain scale responses to placebo or treatment. Download Abstract
The findings of this study were presented at:
- Sports Recovery Seminar - Melbourne, 10th October 2007
- Sports Recovery Seminar - Brisbane, 11th October 2007
- Sports Recovery Seminar - Sydney, 12th October 2007
- Amercian College of Sports Medicine Conference, 28th-31st May 2008, Indianapolis, USA. Download Abstract.
Future presentations of this study will take place at:
- ACSMS 2008 (Sports Medicine Australia), 16-18th October, Hamilton Island, Qld, Australia.
This study will also be published in the following journals:
- Medicine and Science in Sports and Exercise, Volume 40:5 Supplement (abstract only).
Bloodflow, Fibrinolysis and Anti-Procoagulant Activity After Treatment of BodyflowTM in Healthy Subjects – Dr Kurosh Parsi
Dr Kurosh Parsi of Sydney Skin and Vein is one of Australia’s leading Phlebologists. He is an active researcher and president of the Australian College of Phlebology. Parsi has been conducting trials on the Bloodflow, Fibrinolysis and Anti-Procoagulant Activity After Treatment of BodyflowTM in Healthy Subjects.
The findings of this study were presented at:
- Australasian College of Phlebology Conference, 18-21st of September 2007, Double Bay Sydney. Download Abstract